The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2025

Filed:

Nov. 24, 2021
Applicant:

Lankenau Institute for Medical Research, Wynnewood, PA (US);

Inventor:

Sunil Thomas, Philadelphia, PA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/02 (2006.01); A61K 39/00 (2006.01); A61P 31/04 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0225 (2013.01); A61P 31/04 (2018.01); G01N 33/6893 (2013.01); A61K 2039/521 (2013.01); A61K 2039/53 (2013.01); G01N 2333/20 (2013.01); G01N 2800/26 (2013.01);
Abstract

Reagents that include certain identified peptides derived fromproteins, or nucleic acid sequences encoding same are useful in the diagnosis of Lyme borreliosis (Lyme Disease) in infected subject are disclosed herein. Such reagents can also include nucleic acid sequences encoding the peptides. Pharmaceutical compositions useful for the treatment or prophylaxis ofinfection include certain peptides derived fromproteins, or nucleic acid sequences encoding same. Methods of treating or preventing Lyme borreliosis (Lyme Disease) include administering effective amount of such pharmaceutical compositions. An antibody independent prophylactic pharmaceutical composition comprises a sonicate ofbacterium; and methods of treating or preventing Lyme borreliosis include administering effective amounts of that sonicate composition are also disclosed herein.


Find Patent Forward Citations

Loading…